HARDEEP SINGH: Open Payments
NPI 1639369168 · YUBA CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$114 in 3 payments from 3 companies in 2025. Trend: 2023 $239 · 2024 $164 · 2025 $114
Food & beverage: $114
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $56 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
Products named: REXULTI, INGREZZA, COBENFY.
Industry payments across CA — which companies pay providers there.
